Status:

COMPLETED

Trial of PalloV-CC in Colon Cancer

Lead Sponsor:

George E. Peoples

Conditions:

Colon Cancer

Eligibility:

All Genders

18+ years

Phase:

PHASE1

Brief Summary

This study is a phase Ib prospective, open label study evaluating the effect of vaccination on the immune microenvironment of cancers with results compared to banked tissue from historical controls. P...

Detailed Description

This is a single arm, open label, phase Ib trial of neoadjuvant vaccination in colon cancer. The primary endpoint is the safety and toxicity of the vaccine. The primary immunologic endpoint is the imp...

Eligibility Criteria

Inclusion

  • Stage I-IV (resectable) colon cancer patients identified prior to their definitive surgery
  • Diagnosis definitively confirmed by endoscopic biopsy with tumor tissue slides available for analysis
  • Asymptomatic and capable of waiting 4 weeks prior to definitive surgery
  • ECOG 0-1 performance
  • Not involved in other clinical trials
  • Capable of giving informed consent

Exclusion

  • Symptoms of obstruction or GI bleeding that necessitate more urgent surgical intervention
  • Cancer not definitively confirmed on endoscopic biopsy (i.e., Only high-grade dysplasia or adenoma identified, even if malignancy is suspected)
  • Known immune deficiency disease or HIV, active HBV, or active HCV
  • Steroids or other immunosuppressants received within 6 weeks of enrollment
  • Any colon cancer directed treatment (chemotherapy or radiation) received or planned prior to surgical resection
  • A history of any hematologic malignancy or myeloproliferative disease within 5 years prior to enrollment
  • Leukopenia or neutropenia within two weeks of presentation
  • ECOG \>/= 2
  • Pregnancy (serum or urine HCG) or breast feeding
  • Tbili \>1.8, Cr \>2, Hgb \<10, platelet count \<50,000, WBC \<2,000

Key Trial Info

Start Date :

July 20 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 20 2023

Estimated Enrollment :

24 Patients enrolled

Trial Details

Trial ID

NCT03827967

Start Date

July 20 2019

End Date

May 20 2023

Last Update

September 13 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Clinical Associates of Research Therapeutics of America

San Antonio, Texas, United States, 78212